Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $5.50B | $61.86 | $55.33 | -10.55% | Buy | 6 | 70.50% | 211.02% | 560.72% | 151.62% | |||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $40.32B | $301.98 | $438.47 | 45.20% | Strong Buy | 15 | 28.37% | 48.62% | 233.69% | 48.99% | |||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $1.06B | $6.16 | $9.50 | 54.22% | Strong Buy | 2 | 20.80% | 104.39% | 1,840.67% | 61.09% | |||
| CORT | CORCEPT THERAPEUTICS INC | $7.46B | $69.49 | $97.50 | 40.31% | Strong Buy | 4 | 28.92% | 106.23% | 189.22% | 148.15% | |||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $3.72B | $48.38 | $62.20 | 28.57% | Strong Buy | 5 | 19.71% | 36.92% | 40.49% | 29.72% | |||
| KRYS | KRYSTAL BIOTECH INC | $9.11B | $309.03 | $324.11 | 4.88% | Strong Buy | 9 | 28.50% | 21.05% | 67.57% | 61.75% | |||
| ADMA | ADMA BIOLOGICS INC | $1.85B | $7.98 | $19.00 | 138.10% | Strong Buy | 2 | 20.08% | 29.54% | 98.42% | 57.75% | |||
| OMER | OMEROS CORP | $799.02M | $11.04 | $38.00 | 244.20% | Strong Buy | 2 | 261.65% | 19.86% | -310.64% | 68.75% | |||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $11.07B | $57.29 | $87.06 | 51.96% | Strong Buy | 18 | 15.12% | 71.12% | 26.09% | 18.87% | |||
| RPRX | ROYALTY PHARMA PLC | $32.11B | $55.76 | $57.80 | 3.66% | Strong Buy | 5 | 15.14% | 46.46% | 41.61% | 20.87% | |||
| ZVRA | ZEVRA THERAPEUTICS INC | $685.14M | $11.59 | $24.00 | 107.08% | Strong Buy | 2 | 36.34% | 7.93% | 100.35% | 74.13% | |||
| HALO | HALOZYME THERAPEUTICS INC | $7.89B | $66.54 | $88.60 | 33.15% | Strong Buy | 5 | 13.88% | 55.21% | 525.51% | 43.18% | |||
| VCEL | VERICEL CORP | $1.70B | $33.33 | $53.00 | 59.02% | Strong Buy | 2 | 16.37% | 47.55% | 24.71% | 18.13% | |||
| LGND | LIGAND PHARMACEUTICALS INC | $4.65B | $231.96 | $264.00 | 13.81% | Strong Buy | 6 | 17.04% | 20.37% | 28.31% | 18.43% | |||
| ASND | ASCENDIS PHARMA A | $13.92B | $224.11 | $302.55 | 35.00% | Strong Buy | 11 | 34.78% | 10.74% | 263.27% | 64.13% | |||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $14.84B | $236.49 | $256.58 | 8.50% | Strong Buy | 12 | 6.20% | 292.98% | 47.43% | 18.13% | |||
| SPRO | SPERO THERAPEUTICS INC | $163.86M | $2.83 | N/A | N/A | N/A | N/A | -21.95% | 47.53% | N/A | N/A | |||
| TECH | BIO-TECHNE CORP | $8.09B | $51.68 | $64.83 | 25.45% | Buy | 6 | 5.02% | 48.81% | 19.35% | 15.82% | |||
| TGTX | TG THERAPEUTICS INC | $5.81B | $37.94 | $51.67 | 36.18% | Buy | 3 | 32.15% | 1.53% | 104.97% | 40.04% | |||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.83B | $31.59 | $41.33 | 30.84% | Hold | 6 | 13.23% | 26.50% | 25.36% | 18.15% | |||
| UTHR | UNITED THERAPEUTICS CORP | $23.64B | $556.82 | $648.22 | 16.41% | Strong Buy | 9 | 11.62% | 9.46% | 32.70% | 28.74% | |||
| VRTX | VERTEX PHARMACEUTICALS INC | $113.59B | $447.54 | $556.47 | 24.34% | Strong Buy | 19 | 9.79% | 14.01% | 38.19% | 27.92% | |||
| NAGE | NIAGEN BIOSCIENCE INC | $307.43M | $3.86 | $10.50 | 172.02% | Strong Buy | 2 | 15.52% | 16.46% | 41.44% | 29.84% | |||
| EXEL | EXELIXIS INC | $12.69B | $50.48 | $48.00 | -4.91% | Buy | 7 | 11.64% | 13.74% | 69.72% | 52.04% | |||
| CPRX | CATALYST PHARMACEUTICALS INC | $3.82B | $31.23 | $31.50 | 0.86% | Hold | 2 | 9.44% | 8.81% | 57.07% | 50.36% | |||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $170.01M | $2.11 | $12.00 | 468.72% | Buy | 1 | -5.52% | 14.32% | 13.31% | 8.75% | |||
| REGN | REGENERON PHARMACEUTICALS INC | $64.45B | $614.78 | $823.61 | 33.97% | Strong Buy | 18 | 9.59% | 15.29% | 24.71% | 19.00% | |||
| VCYT | VERACYTE INC | $3.70B | $46.34 | $44.83 | -3.25% | Buy | 6 | 10.67% | 17.40% | 13.14% | 12.30% | |||
| SRPT | SAREPTA THERAPEUTICS INC | $1.89B | $17.87 | $26.33 | 47.36% | Hold | 6 | -14.05% | 7.14% | 18.77% | 8.89% | |||
| INCY | INCYTE CORP | $19.33B | $96.74 | $107.71 | 11.34% | Buy | 14 | 7.51% | 11.32% | 13.36% | 10.24% | |||
| MDXG | MIMEDX GROUP INC | $548.12M | $3.68 | $8.20 | 122.83% | Strong Buy | 5 | -3.90% | 6.45% | 12.51% | 9.84% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.